Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online June 29, 2007
Diabetes 56:2638-2642, 2007
DOI: 10.2337/db07-0012
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
db07-0012v1
56/10/2638    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sale, M. M.
Right arrow Articles by Freedman, B. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sale, M. M.
Right arrow Articles by Freedman, B. I.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Brief Report

Variants of the Transcription Factor 7-Like 2 (TCF7L2) Gene Are Associated With Type 2 Diabetes in an African-American Population Enriched for Nephropathy

Michèle M. Sale1,2,3,4,5, Shelly G. Smith1, Josyf C. Mychaleckyj3,6,7, Keith L. Keene1, Carl D. Langefeld7, Tennille S. Leak1, Pamela J. Hicks1,8, Donald W. Bowden1,2,8, Stephen S. Rich3,4,6, and Barry I. Freedman2

1 Center for Human Genomics, Wake Forest University School of Medicine, Winston-Salem, North Carolina
2 Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina
3 Center for Public Health Genomics, University of Virginia, Charlottesville, Virginia
4 Department of Medicine, University of Virginia, Charlottesville, Virginia
5 Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, Virginia
6 Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia
7 Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina
8 Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, North Carolina

Address correspondence and reprint requests to Michèle M. Sale, PhD, Center for Public Health Genomics, University of Virginia, P.O. Box 800717, Charlottesville, VA 22908. E-mail: msale{at}virginia.edu

Abbreviations: AIM, ancestry-informative marker; HWE, Hardy-Weinberg equilibrium; SNP, single nucleotide polymorphism

OBJECTIVE—Recently, variants in the TCF7L2 gene have been reported to be associated with type 2 diabetes across multiple Europid populations, but only one small sample of African-American type 2 diabetic patients has been examined. Our objective was to investigate the importance of TCF7L2 in a larger African-American case-control population.

RESEARCH DESIGN AND METHODS—We investigated single nucleotide polymorphisms (SNPs) in six known type 2 diabetes genes in 577 African-American case subjects with type 2 diabetes enriched for nephropathy and 596 African-American control subjects. Additionally, we genotyped 70 ancestry-informative markers (AIMs) to apply adjustments for differences in ancestral proportions.

RESULTS—The most significant associations were observed with TCF7L2 intron 3 SNPs rs7903146 (additive P = 4.10 x 10–6, odds ratio [OR] 1.51; admixture-adjusted Pa = 3.77 x 10–6) and rs7901695 (P = 0.001, OR 1.30; Pa = 0.003). The 2-SNP haplotype containing these SNPs was also associated with type 2 diabetes (P = 3 x 10–5). Modest associations were also seen with TCF7L2 intron 4 SNPs rs7895340, rs11196205, and rs12255372 (0.01 < P < 0.05; 0.03 < Pa < 0.08), as well as with ATP-sensitive inwardly rectifying potassium channel subunit Kir6.2 (KCNJ11) and hepatocyte nuclear factor 4-{alpha} (HNF4A) SNPs (0.01 < P < 0.05; 0.01 < Pa < 0.41). No significant associations were detected with genotyped calpain 10 (CAPN10), peroxisome proliferator–activated receptor {gamma} (PPARG), and transcription factor 1 (TCF1) SNPs.

CONCLUSIONS—This study indicates that variants in the TCF7L2 gene significantly contribute to diabetes susceptibility in African-American populations.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
K. L. Keene, J. C. Mychaleckyj, S. G. Smith, T. S. Leak, P. S. Perlegas, C. D. Langefeld, B. I. Freedman, S. S. Rich, D. W. Bowden, and M. M. Sale
Association of the Distal Region of the Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 Gene With Type 2 Diabetes in an African-American Population Enriched for Nephropathy
Diabetes, April 1, 2008; 57(4): 1057 - 1062.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. O. Goodarzi and J. I. Rotter
Testing the Gene or Testing a Variant?: The Case of TCF7L2
Diabetes, October 1, 2007; 56(10): 2417 - 2419.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.